New treatment options allow patients with chronic lymphocytic leukemia (CLL) to live longer than they used to with the former standard of care, chlorambucil-based chemotherapy. Clinical trials are underway for a variety of options:
Through clinical trials, doctors are able to carefully study and learn which new regimens are better at treating CLL. They’re also one of the best ways for patients to get state-of-the-art cancer treatment. You can find out if you’re eligible for a clinical trial by talking with your doctor or checking ClinicalTrials.gov.
Experts talk to Survivornet about the significant new advances in treating patients who have recently been diagnosed with later-stage CLL.
For patients diagnosed with CLL, the go-to treatment option is usually some form of chemo-immunotherapy. But this is not an option for all patients.
Oral Medicine for Relapsed CLL: Venetoclax
Oral Medicine for CLL: Ibrutinib
Oral Medicine for Relapsed CLL